VivoSeq
Oncology

Locally Advanced Cancer

0

Pipeline Programs↗

0

Active Trials↗

3

Companies Involved↗

Locally Advanced Cancer is an early-stage landscape with 0 programs across 3 companies. The most active players are Radiation Therapy Oncology Group, Roche, Gynecologic Oncology Group.

Intelligence

Pipeline Metrics

Competitive Density

0/100

Pipeline Velocity

0/100

Mech. Concentration

N/A

Completion Rate

89/100

Attrition Rate

10/100

Competition

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Key Players

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

Radiation Therapy Oncology Group logo

Radiation Therapy Oncology Group

0 programs

PreclinicalRoche logo

Roche

0 programs

PreclinicalG

Gynecologic Oncology Group

0 programs

Preclinical

Pipeline

Programs by Phase

No pipeline programs currently tracked for this disease.

Analysis

Trial Status

10

clinical trials

Completed8 · 80%
Terminated1 · 10%
Unknown status1 · 10%

Clinical Trials

Trial Activity

10 trials

A Continuation Study of Herceptin (Trastuzumab) in Participants With Metastatic or Locally Advanced Cancer
Completed·Roche logoRoche·Phase 3·NCT02721641·69 enrolled
Ganitumab and Gemcitabine Hydrochloride Followed by Radiation Therapy, Ganitumab, Capecitabine, and Maintenance Therapy in Treating Patients With Locally Advanced Cancer of the Pancreas
Completed·Radiation Therapy Oncology Group logoRadiation Therapy Oncology Group·Phase 1·NCT01298401·8 enrolled
Chemotherapy, Radiation Therapy, and Surgery in Treating Patients With Locally Advanced Cancer of the Vulva
Completed·GGynecologic Oncology Group·Phase 2·NCT00068406·61 enrolled
Radiation Therapy Plus Fludarabine in Treating Patients With Locally Advanced Cancer of the Mouth, Pharynx, or Larynx
Completed·MM.D. Anderson Cancer Center·Phase 1·NCT00004246·16 enrolled
Radiation Therapy Plus Chemotherapy Followed by Surgery in Treating Patients With Locally Advanced Cancer of the Rectum
Completed·Radiation Therapy Oncology Group logoRadiation Therapy Oncology Group·Phase 2·NCT00006366
Oxaliplatin, Capecitabine, and Radiation Therapy in Treating Patients With Locally Advanced Cancer of the Rectum
Completed·RRoswell Park Cancer Institute·Phase 1/2·NCT00086931·37 enrolled
Combination Chemotherapy and Radiation Therapy With or Without Lapatinib in Treating Patients With Locally Advanced Cancer of the Larynx or Hypopharynx
Completed·EEuropean Organisation for Research and Treatment of Cancer - EORTC·Phase 1/2·NCT00498953·7 enrolled
Oxaliplatin, Fluorouracil, and External-Beam Radiation Therapy Followed by Surgery in Treating Patients With Locally Advanced Cancer of the Rectum
Completed·National Cancer Institute (NCI)·Phase 1/2·NCT00006094·24 enrolled
Chemotherapy Plus Radiation Therapy With or Without Amifostine in Treating Patients With Locally Advanced Cancer of the Nasopharynx
Terminated·EEuropean Organisation for Research and Treatment of Cancer - EORTC·Phase 2·NCT00025298·5 enrolled
Induction Chemotherapy, FOLFIRINOX Followed With Concurrent Capecitabine and Radiation Therapy in Inoperable Locally Advanced Cancer of the Pancreas
Unknown status·—·Phase 2/3·NCT02311439·1 enrolled

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)